Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Richardson

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Asia-Pacific Journal of Clinical Oncology|August 8, 2025
Disparities in Timeliness and Guideline-Concordant Treatment is Associated With Excess Mortality in Public Versus Private Lung Cancer PatientsJonathan Pham, Tiffany Lin, Eldho Paul, et al.
Clinical Colorectal Cancer|January 25, 2016
Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative IntentShu Fen Wong, Hui Li Wong, Kathryn M Field, et al.
ANZ Journal of Surgery|March 29, 2007
A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601Michael Findlay, David Storey, Val Gebski, et al.
BMC Health Services Research|July 8, 2024
Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challengesYael R Lefkovits, Natalie Heriot, Alice Sporik, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in AustraliaNatalie Heather Turner, Hui-Li Wong, Kathryn Field, et al.
JCO Oncology Practice|January 14, 2026
Quality Matters: Linking Patterns of Care to Ovarian Cancer Survival in a National Gynae-Oncology RegistryMahendra Naidoo, Orla McNally, Clare L Scott, et al.
British Journal of Cancer|December 4, 2025
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancerNoboru Yamamoto, Dong Yan, Vinod Ganju, et al.
Breast Cancer Research and Treatment|August 12, 2020
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancerYada Kanjanapan, Sheau Wen Lok, Peter Gibbs, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology RegistryYeh Chen Lee, Aleesha Whitely, Michael Burling, et al.
JCO Precision Oncology|January 7, 2022
Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant PheochromocytomaAngela Mweempwa, Huiling Xu, Joseph H A Vissers, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Asia-Pacific Journal of Clinical Oncology|August 8, 2025
Disparities in Timeliness and Guideline-Concordant Treatment is Associated With Excess Mortality in Public Versus Private Lung Cancer PatientsJonathan Pham, Tiffany Lin, Eldho Paul, et al.
Clinical Colorectal Cancer|January 25, 2016
Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative IntentShu Fen Wong, Hui Li Wong, Kathryn M Field, et al.
ANZ Journal of Surgery|March 29, 2007
A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601Michael Findlay, David Storey, Val Gebski, et al.
BMC Health Services Research|July 8, 2024
Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challengesYael R Lefkovits, Natalie Heriot, Alice Sporik, et al.
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in AustraliaNatalie Heather Turner, Hui-Li Wong, Kathryn Field, et al.
JCO Oncology Practice|January 14, 2026
Quality Matters: Linking Patterns of Care to Ovarian Cancer Survival in a National Gynae-Oncology RegistryMahendra Naidoo, Orla McNally, Clare L Scott, et al.
British Journal of Cancer|December 4, 2025
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancerNoboru Yamamoto, Dong Yan, Vinod Ganju, et al.
Breast Cancer Research and Treatment|August 12, 2020
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancerYada Kanjanapan, Sheau Wen Lok, Peter Gibbs, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology RegistryYeh Chen Lee, Aleesha Whitely, Michael Burling, et al.
JCO Precision Oncology|January 7, 2022
Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant PheochromocytomaAngela Mweempwa, Huiling Xu, Joseph H A Vissers, et al.
Pageof 6